Margaret G Mcglynn Novavax Inc (NVAX) insider trading activity

Margaret G Mcglynn is Director of NOVAVAX INC. Currently has a direct ownership of 15,168 shares of NVAX, which is worth approximately $121,192. The most recent transaction as insider was on Dec 31, 2024, when has been sold 1,178 shares (Common Stock) at a price of $8.61 per share, resulting in proceeds of $10,142. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.2K

8.42% 3M change

299.16% 12M change

Total Value Held $121,192

MARGARET G MCGLYNN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2024	BUY Grant, award, or other acquisition	$10,142 $8.61 p/Share	1,178 Added 7.21%	15,168 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	$9,935 $12.77 p/Share	778 Added 5.27%	13,990 Common Stock
Jun 30 2024	BUY Grant, award, or other acquisition	$9,932 $13.93 p/Share	713 Added 5.12%	13,212 Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	-	6,670 Added 38.91%	10,470 Common Stock
Mar 31 2024	BUY Grant, award, or other acquisition	$9,942 $4.9 p/Share	2,029 Added 25.82%	5,829 Common Stock
Jun 10 2023	BUY Exercise of conversion of derivative security	-	3,100 Added 44.93%	3,800 Common Stock
Jun 17 2022	BUY Exercise of conversion of derivative security	-	700 Added 50.0%	700 Common Stock

Also insider at

APD

Air Products & Chemicals, Inc. Basic Materials

Director

VRTX

VERTEX PHARMACEUTICALS INC Healthcare

Director

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

MGM